HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 4.400
0.00 (0.00%)
At close: Mar 20, 2026
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of CAD 137.6 million as of March 20, 2026. Its market cap has increased by 6.08% in one year.
Market Cap
137.60M
Enterprise Value
189.84M
Revenue
76.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.40
Market Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 317.91M to 137.60M, a decrease of -56.72%. That is a compound annual growth rate of -9.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 137.60M | -8.71% |
| Dec 31, 2025 | 150.74M | 20.64% |
| Dec 31, 2024 | 124.95M | -1.37% |
| Dec 29, 2023 | 126.68M | -60.20% |
| Dec 30, 2022 | 318.33M | -34.60% |
| Dec 31, 2021 | 486.77M | -14.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 265.34M |
| Organigram Global | 257.68M |
| Aurora Cannabis | 255.76M |
| Auxly Cannabis Group | 182.66M |
| Cannara Biotech | 179.78M |
| BioSyent | 179.74M |
| Charlotte's Web Holdings | 158.09M |
| Cardiol Therapeutics | 143.11M |